Dentalife Australia, a leading Australian developer and manufacturer of Dental and Infection Control products is announcing its Clinicare Hospital Grade Disinfectant has been reformulated to kill SARS-CoV-2 (Covid-19). The new formula has been approved under the Therapeutic Goods Order 104, which allows disinfectants to be listed with claims to kill the SARS-CoV-2 (Covid-19) virus.
Dentalife can confirm Clinicare Hospital Grade Disinfectant is listed on TGA’s Disinfectant for use against Covid-19 in the ARTG for legal supply in Australia. Clinicare Hospital Grade Disinfectant has been tested and validated to kill SARS-CoV-2 (Covid-19) in just 2 minutes.
Company General Manager, Tom Stray says, “The 2-minute Covid-19 kill time will have a major advantage for dental clinics and other medical facilities as wait times to disinfectant surfaces between patients decreases significantly. This will allow for improved efficiencies in infection control policy and procedures.”
Tom went on to say, “We are proud that this disinfectant was developed in Australia and is being manufactured right here in our Melbourne facility.”
The Clinicare Hospital Grade disinfectant is intended to be used as a surface disinfectant and decontaminant and is be available in Wipes, 500ml Trigger spray, 500mL Squirt bottles and 5L bulk packaging.
Australia Dentalife is an Australian research, development and manufacturing company specialising in Dental and Infection Control products. Dentalife is a 100% Australian owned company. www.dentalife.com.au